Tag:
prostate cancer
Latest Headlines
Latest Headlines
Mayo Clinic's prostate cancer imaging agent hampered by limited access
With great fanfare, the Mayo Clinic won FDA approval late last year for a new diagnostic imaging agent that helps determine when prostate cancer has returned. But as Bloomberg reports, the non-profit medical center has struggled to expand access to the compound.
Patch-delivered estrogen treats prostate cancer with fewer side effects
Researchers in the U.K. have found that an estrogen patch is an effective way to treat prostate cancer compared with side effects-laden hormone injections and pills.
Retargeted bird virus could provide new treatment for prostate cancer
A potential treatment for prostate cancer has an unlikely origin--a zoonotic disease. Scientists from Virginia Polytechnic Institute are tapping a Newcastle disease virus that kills prostate cancer cells, including hormone-resistant cells, but leaves normal cells intact, as a potential new drug.
MDxHealth hits testing milestone with prostate cancer epigenetic Dx
MDxHealth ($MDXH) is celebrating positive results from recent studies of its prostate cancer molecular diagnostic test.
MDxHealth hits testing milestone with prostate cancer epigenetic Dx
MDxHealth is celebrating positive results from recent studies of its prostate cancer molecular diagnostic test.
True Diagnostics revs up EU prostate cancer Dx launch
True Diagnostics gained a CE mark for its new quantitative prostate cancer diagnostic test, and the California startup will initially start selling it through distribution partners in Germany, the U.K., France, Italy and Spain.
ScinoPharm, Foresee partner to deliver cancer drug
Taiwanese drugmaker ScinoPharm will use Foresee Pharmaceuticals' controlled-release technology to produce a generic prostate cancer drug.
Beta blockers could improve cancer treatment in stressed patients
In a mouse study, stress stopped cancer drugs from working but beta blockers may kick-start the treatment again.
Seeing is believing: Biomarkers visible to the naked eye
Researchers at Imperial College London have created a prototype ultra-sensitive visual test based on gold nanoparticles that can make detecting disease and infection biomarkers possible at a glance.
U.K. researchers spot new marker for prostate cancer prognosis
A protein that helps cells stick together could be a marker for the severity of prostate cancer, according to lab research at the U.K.'s University of Manchester. The protein, β2-syntrophin, helps cells make tight connections to each other, which helps to stop tumors from spreading.
